Huge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
DEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicinePractice ManagementRenal Cell CarcinomaSarcoma & GISTCNS/Brain CancerDLBCLFollicular Lymphoma
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CarePractice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Cancer drug shortages spur worry, rationing, and tough choicesJune 16, 2023Patient & Survivor CareDLBCLMixed TopicsGastrointestinal Cancer
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncologyJune 15, 2023Mixed TopicsBreast CancerPatient & Survivor CareMetastatic Breast CancerMelanomaRare DiseasesRenal Cell Carcinoma
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CarePractice ManagementLung CancerBreast CancerGenitourinary CancerNonmelanoma Skin CancerMetastatic Breast Cancer
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareLung CancerDiversity in MedicineBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Study shows higher obesity-related cancer mortality in areas with more fast foodMay 5, 2023Preventive CareCNS/Brain CancerDLBCLGastrointestinal CancerFollicular LymphomaGenitourinary CancerGynecologic Cancer
Rituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesLymphoma & Plasma Cell DisordersDLBCL
Real-world CAR T outcomes for DLBCL mimic clinical trialsJune 28, 2021DLBCLLymphoma & Plasma Cell Disorders
Experimental antibody-drug conjugate shown active against r/r DLBCLJune 15, 2021DLBCLLymphoma & Plasma Cell Disorders
Choosing the right R-CHOP dosage for elderly patients with DLBCLJune 8, 2021DLBCLLymphoma & Plasma Cell Disorders
High-dose methotrexate of no CNS benefit for patients with high-risk DLBCLMay 18, 2021DLBCLLymphoma & Plasma Cell Disorders
Evidence favors lower-dose R-CHOP for fit, very elderly DLBCL patientsApril 14, 2021DLBCLLymphoma & Plasma Cell Disorders
Poor survival with COVID in patients who have had HSCTMarch 26, 2021Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersDLBCL
